Targeted News Service logo

-- Preview Email Newsletter
U.S. Congressional Tipoffs Involving Maine Newsletter for 2025-01-29 ( 3 items )  
"It is Blatantly Unconstitutional," King Declares in Response to Proposed Federal Grant, Loan Freeze (10)
WASHINGTON, Jan. 28 -- Sen. Angus S. King Jr., I-Maine, issued the following news release: * * * "It is Blatantly Unconstitutional," King Declares in Response to Proposed Federal Grant, Loan Freeze Watch or download the full remarks here WASHINGTON, D.C.--In a press conference on Capitol Hill today, Senator Angus King (I-ME), declared that President Donald Trump's proposal to halt all federal grant and loan disbursement is unconstitutional. He cited Article 2 of the Constitution which clearly lays out the role of the President as an enforc more PR

In Veterans Affairs Hearing, King Argues VA Hiring Freeze, Lack of Health Care Data Essentially a "Denial of Benefits" (10)
WASHINGTON, Jan. 28 -- Sen. Angus S. King Jr., I-Maine, issued the following news release: * * * In Veterans Affairs Hearing, King Argues VA Hiring Freeze, Lack of Health Care Data Essentially a "Denial of Benefits" WASHINGTON, D.C. -- U.S. Senator Angus King today argued that a lack of health care data and the current Department of Veterans Affairs (VA) hiring freeze are denying veterans the benefits they rightly deserve. In a hearing of the Senate Veterans Affairs Committee (SVAC), King questioned Naomi Mathis, the Assistant National Legis more PR

King Cosponsors Bipartisan Bill to Increase Price Transparency on Prescription Drug Advertising (10)
WASHINGTON, Jan. 28 -- Sen. Angus S. King Jr., I-Maine, issued the following news release: * * * King Cosponsors Bipartisan Bill to Increase Price Transparency on Prescription Drug Advertising WASHINGTON, D.C. -- U.S. Senator Angus King (I-ME) is cosponsoring legislation to promote transparency, boost competition, and bring down the cost of prescription drugs. The bipartisan Drug-Price Transparency for Consumers (DTC) Act would require price disclosures on advertisements for prescription drugs in order to inform patients who are considering  more PR